File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.7554/eLife.86266
- Scopus: eid_2-s2.0-85159541770
- WOS: WOS:000986671700001
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: COVID-19 as a catalyst for reimagining cervical cancer prevention
Title | COVID-19 as a catalyst for reimagining cervical cancer prevention |
---|---|
Authors | |
Issue Date | 18-Apr-2023 |
Publisher | eLife Sciences Publications |
Citation | eLife, 2023, v. 12 How to Cite? |
Abstract | Cervical cancer has killed millions of women over the past decade. In 2019 the World Health Organization launched the Cervical Cancer Elimination Strategy, which included ambitious targets for vaccination, screening, and treatment. The COVID-19 pandemic disrupted progress on the strategy, but lessons learned during the pandemic – especially in vaccination, self-administered testing, and coordinated mobilization on a global scale – may help with efforts to achieve its targets. However, we must also learn from the failure of the COVID-19 response to include adequate representation of global voices. Efforts to eliminate cervical cancer will only succeed if those countries most affected are involved from the very start of planning. In this article we summarize innovations and highlight missed opportunities in the COVID response, and make recommendations to leverage the COVID experience to accelerate the elimination of cervical cancer globally. |
Persistent Identifier | http://hdl.handle.net/10722/329071 |
ISSN | 2023 Impact Factor: 6.4 2023 SCImago Journal Rankings: 3.932 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Luckett, R | - |
dc.contributor.author | Feldman, S | - |
dc.contributor.author | Woo, YL | - |
dc.contributor.author | Moscicki, AB | - |
dc.contributor.author | Giuliano, AR | - |
dc.contributor.author | de Sanjose, S | - |
dc.contributor.author | Kaufmann, AM | - |
dc.contributor.author | Leung, SOA | - |
dc.contributor.author | Garcia, F | - |
dc.contributor.author | Chan, K | - |
dc.contributor.author | Bhatla, N | - |
dc.contributor.author | Stanley, M | - |
dc.contributor.author | Brotherton, J | - |
dc.contributor.author | Palefsky, J | - |
dc.contributor.author | Garland, S | - |
dc.date.accessioned | 2023-08-05T07:55:04Z | - |
dc.date.available | 2023-08-05T07:55:04Z | - |
dc.date.issued | 2023-04-18 | - |
dc.identifier.citation | eLife, 2023, v. 12 | - |
dc.identifier.issn | 2050-084X | - |
dc.identifier.uri | http://hdl.handle.net/10722/329071 | - |
dc.description.abstract | <p>Cervical cancer has killed millions of women over the past decade. In 2019 the World Health Organization launched the Cervical Cancer Elimination Strategy, which included ambitious targets for vaccination, screening, and treatment. The COVID-19 pandemic disrupted progress on the strategy, but lessons learned during the pandemic – especially in vaccination, self-administered testing, and coordinated mobilization on a global scale – may help with efforts to achieve its targets. However, we must also learn from the failure of the COVID-19 response to include adequate representation of global voices. Efforts to eliminate cervical cancer will only succeed if those countries most affected are involved from the very start of planning. In this article we summarize innovations and highlight missed opportunities in the COVID response, and make recommendations to leverage the COVID experience to accelerate the elimination of cervical cancer globally.</p> | - |
dc.language | eng | - |
dc.publisher | eLife Sciences Publications | - |
dc.relation.ispartof | eLife | - |
dc.rights | This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. | - |
dc.title | COVID-19 as a catalyst for reimagining cervical cancer prevention | - |
dc.type | Article | - |
dc.identifier.doi | 10.7554/eLife.86266 | - |
dc.identifier.scopus | eid_2-s2.0-85159541770 | - |
dc.identifier.volume | 12 | - |
dc.identifier.eissn | 2050-084X | - |
dc.identifier.isi | WOS:000986671700001 | - |
dc.identifier.issnl | 2050-084X | - |